Pharma BD Deal Intelligence
Bayer AG / Asklepios BioPharmaceuticals
2020 · Acquisition/Merger · $2.0B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
49
Mixed — partial payoff, real shortfalls.
Bayer acquired AskBio for $2B for investigational gene therapy compounds.
Key facts
- Announced Oct 26, 2020
- Closed Dec 31, 2020
- Deal value $2.0B
- Deal type Acquisition/Merger
- Therapeutic area Cardiovascular, Gene Therapy, Neurology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals